vs
Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and Metalpha Technology Holding Ltd (MATH). Click either name above to swap in a different company.
Gossamer Bio, Inc. is the larger business by last-quarter revenue ($13.8M vs $12.0M, roughly 1.1× Metalpha Technology Holding Ltd). Metalpha Technology Holding Ltd runs the higher net margin — -24.0% vs -342.3%, a 318.3% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs -39.0%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
Metalpha Technology Holding LtdMATHEarnings & Financial Report
Metalpha Technology Holding Ltd is a global fintech firm specializing in digital asset wealth management, institutional-grade crypto investment services, and Web3 ecosystem infrastructure support. It serves professional investors, financial institutions, and high-net-worth clients across Asia, North America and Europe, with core segments including structured digital asset products, risk management solutions and DeFi technology development.
GOSS vs MATH — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $12.0M |
| Net Profit | $-47.2M | $-2.9M |
| Gross Margin | — | 28.3% |
| Operating Margin | -333.6% | -24.2% |
| Net Margin | -342.3% | -24.0% |
| Revenue YoY | 47.1% | -39.0% |
| Net Profit YoY | -43.0% | -147.7% |
| EPS (diluted) | $-0.21 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | — | ||
| Q3 25 | $13.3M | $12.0M | ||
| Q1 25 | — | $24.8M | ||
| Q3 24 | — | $19.7M | ||
| Q2 24 | $95.8M | — | ||
| Q1 24 | $0 | — | ||
| Q3 23 | $0 | — | ||
| Q2 23 | $0 | — |
| Q4 25 | $-47.2M | — | ||
| Q3 25 | $-48.2M | $-2.9M | ||
| Q1 25 | — | $9.8M | ||
| Q3 24 | — | $6.0M | ||
| Q2 24 | $49.2M | — | ||
| Q1 24 | $-41.9M | — | ||
| Q3 23 | $-40.0M | — | ||
| Q2 23 | $-42.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 28.3% | ||
| Q1 25 | — | 85.7% | ||
| Q3 24 | — | 49.5% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | -333.6% | — | ||
| Q3 25 | -369.4% | -24.2% | ||
| Q1 25 | — | 39.3% | ||
| Q3 24 | — | 38.9% | ||
| Q2 24 | 54.3% | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | -342.3% | — | ||
| Q3 25 | -362.7% | -24.0% | ||
| Q1 25 | — | 39.6% | ||
| Q3 24 | — | 30.7% | ||
| Q2 24 | 51.4% | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | $-0.21 | — | ||
| Q3 25 | $-0.21 | $-0.07 | ||
| Q1 25 | — | $0.25 | ||
| Q3 24 | — | $0.16 | ||
| Q2 24 | $0.22 | — | ||
| Q1 24 | $-0.19 | — | ||
| Q3 23 | $-0.21 | — | ||
| Q2 23 | $-0.45 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.9M | $10.1M |
| Total DebtLower is stronger | — | $101.2K |
| Stockholders' EquityBook value | $-122.8M | $35.1M |
| Total Assets | $172.2M | $413.8M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.9M | — | ||
| Q3 25 | $180.2M | $10.1M | ||
| Q1 25 | — | $6.9M | ||
| Q3 24 | — | $3.8M | ||
| Q2 24 | $354.5M | — | ||
| Q1 24 | $244.4M | — | ||
| Q3 23 | $328.9M | — | ||
| Q2 23 | $162.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $101.2K | ||
| Q1 25 | — | $188.0K | ||
| Q3 24 | — | $275.1K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | $-122.8M | — | ||
| Q3 25 | $-82.3M | $35.1M | ||
| Q1 25 | — | $36.6M | ||
| Q3 24 | — | $25.3M | ||
| Q2 24 | $81.5M | — | ||
| Q1 24 | $26.7M | — | ||
| Q3 23 | $104.6M | — | ||
| Q2 23 | $-62.8M | — |
| Q4 25 | $172.2M | — | ||
| Q3 25 | $208.8M | $413.8M | ||
| Q1 25 | — | $246.8M | ||
| Q3 24 | — | $237.2M | ||
| Q2 24 | $373.4M | — | ||
| Q1 24 | $259.4M | — | ||
| Q3 23 | $347.9M | — | ||
| Q2 23 | $181.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q1 25 | — | 0.01× | ||
| Q3 24 | — | 0.01× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.3M | $3.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.3M | — | ||
| Q3 25 | $-36.2M | $3.3M | ||
| Q1 25 | — | $16.2M | ||
| Q3 24 | — | $-16.1M | ||
| Q2 24 | $116.3M | — | ||
| Q1 24 | $-52.3M | — | ||
| Q3 23 | $-34.5M | — | ||
| Q2 23 | $-38.3M | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q1 25 | — | 1.64× | ||
| Q3 24 | — | -2.66× | ||
| Q2 24 | 2.36× | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
